NCT01696513
Active, not recruiting
Not Applicable
Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Subcision and Suctioning with a Microdermabrasion Device on Rolling Acne Scars
ConditionsAcne Scars
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acne Scars
- Sponsor
- Northwestern University
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Change in acne scarring compared to baseline after treatments
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
The primary objective of this study is to determine whether the use of standard treatment in conjunction with suction will improve acne scars compared to a standard treatment alone.
Investigators
Murad Alam
Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation
Northwestern University
Eligibility Criteria
Inclusion Criteria
- •Age 18 and over
- •Have bilateral rolling acne scars
- •Are in good health
- •Subject has the willingness and ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
Exclusion Criteria
- •Under 18 years of age
- •Pregnancy or lactation
- •Unable to understand the protocol or give informed consent
- •Has mental illness
- •Recent Accutane use in the past 6 months
- •Prone to hypertrophic and keloidal scarring
Outcomes
Primary Outcomes
Change in acne scarring compared to baseline after treatments
Time Frame: Baseline and 4 months
The change in acne scarring is measured using a global scarring grading system to compare baseline scarring to the treatments.
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Phase 4
Injection Assistance Device Versus Manual Injections for Delivery of Dermal FillersCorrection of Nasolabial FoldsNCT01492140TKL Research, Inc.50
Completed
Not Applicable
A Trial Assessing The Association Between Type Of Local Anesthesia Treatment And Postoperative Pain In Patients In Having Undergone Arrhythmia SurgeryPost-operative PainNCT01300377Baylor Research Institute300
Completed
Phase 4
EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple SclerosisMultiple SclerosisNCT00146068University of North Carolina30
Completed
Phase 2
Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)Rheumatoid ArthritisNCT00664521Merck KGaA, Darmstadt, Germany27
Unknown
Phase 3
Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary BypassPrevention of Venous ThromboembolismNCT01072747Azidus Brasil104